64 Stocks Moving In Friday’s Mid-Day Session
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.
CORRECTION: Credit Suisse Maintains Neutral on Shake Shack, Lowers Price Target to $92
CORRECTION:Credit Suisse analyst Lauren Silberman maintains Shake Shack (NYSE:SHAK) with a Neutral and lowers the price target from $102 to $92.
Credit Suisse Maintains Neutral on Shake Shack, Raises Price Target to $102
Credit Suisse analyst Lauren Silberman maintains Shake Shack (NYSE:SHAK) with a Neutral and raises the price target from $92 to $102.
Cowen & Co. Maintains Market Perform on Shake Shack, Lowers Price Target to $82
Cowen & Co. analyst Andrew Charles maintains Shake Shack (NYSE:SHAK) with a Market Perform and lowers the price target from $86 to $82.
UPDATE: Josh Brown Says Shake Shake ‘Might Still Be In The Penalty Box With A Lot Of Other Quick-Service Restaurants…’
-CNBC's "Fast Money: Halftime Report"
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
What 8 Analyst Ratings Have To Say About Shake Shack
Shake Shack (NYSE:SHAK) has observed the following analyst ratings within the last quarter:
Northcoast Research Upgrades Shake Shack to Buy, Announces $98 Price Target
Northcoast Research analyst Jim Sanderson upgrades Shake Shack (NYSE:SHAK) from Neutral to Buy and announces $98 price target.